Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inorganic Polyphosphates As Storage for and Generator of Metabolic Energy in the Extracellular Matrix. | Chem Rev | 2019 | 31738523 | PubTator, text mining | PubMed |
| Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications. | Front Immunol | 2019 | 31736936 | PubTator, text mining | PubMed |
| Biomimetic Nanoparticle Vaccines for Cancer Therapy. | Adv Biosyst | 2019 | 31728404 | PubTator, text mining | PubMed |
| Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. | J Immunother Cancer | 2019 | 31727154 | PubTator, text mining | PubMed |
| Radium-223 mechanism of action: implications for use in treatment combinations. | Nat Rev Urol | 2019 | 31712765 | PubTator, text mining | PubMed |
| Differential seminal plasma proteome signatures of acute lymphoblastic leukemia survivors. | Reprod Biol | 2019 | 31711845 | PubTator, text mining | PubMed |
| Advances in Engineering Cells for Cancer Immunotherapy. | Theranostics | 2019 | 31695806 | PubTator, text mining | PubMed |
| The Polyphenols as Potential Agents in Prevention and Therapy of Prostate Diseases. | Molecules | 2019 | 31689909 | PubTator, text mining | PubMed |
| Identification of modules and hub genes associated with platinum-based chemotherapy resistance and treatment response in ovarian cancer by weighted gene co-expression network analysis. | Medicine (Baltimore) | 2019 | 31689861 | PubTator, text mining | PubMed |
| Adenosine Depletion as A New Strategy to Decrease Glioblastoma Stem-Like Cells Aggressiveness. | Cells | 2019 | 31671624 | PubTator, text mining | PubMed |
| Importance of 14-3-3eta, anti-CarP, and anti-Sa in the diagnosis of seronegative rheumatoid arthritis | Turk J Med Sci | 2019 | 31651120 | PubTator, text mining | PubMed |
| Immunotherapeutic Challenges for Pediatric Cancers. | Mol Ther Oncolytics | 2019 | 31650024 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives. | Oncoimmunology | 2019 | 31646092 | PubTator, text mining | PubMed |
| Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer. | J Clin Oncol | 2019 | 31644357 | PubTator, text mining | PubMed |
| CAR-T cell therapy: a potential new strategy against prostate cancer. | J Immunother Cancer | 2019 | 31619289 | PubTator, text mining | PubMed |
| 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells. | Cancers (Basel) | 2019 | 31614463 | PubTator, text mining | PubMed |
| Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy. | Cancer Immunol Immunother | 2019 | 31606777 | PubTator, text mining | PubMed |
| Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach. | Biomolecules | 2019 | 31600936 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods. | PeerJ | 2019 | 31598425 | PubTator, text mining | PubMed |
| Dual-targeting nanotherapeutics antagonize hyperinsulinemia-promoted tumor growth via activating cell autophagy. | J Mater Chem B | 2019 | 31593205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=42